NT ‐proBNP predicts the cardio‐renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - July 10, 2018 Category: Endocrinology Authors: Nienke M.A. Idzerda , Frederik Persson , Michelle J. Pena , Barry M. Brenner , Patrick Brunel , Nish Chaturvedi , John J. McMurray , Hans ‐Henrik Parving , Dick de Zeeuw , Hiddo J. L. Heerspink Source Type: research